News & Blog

News & Blog

  • Reset
Blog | Oct 28 2024

Meet The Community: Daniel Huber

Community
Blog | Oct 21 2024

Meet The Community: Kendall Harvey

Community
News | Oct 16 2024

Papillon Therapeutics Receives Rare Pediatric Disease Designation from the U.S. Food and Drug Administration for PPL-001 for the Treatment of Friedreich’s Ataxia

Industry News
Blog | Oct 14 2024

2024 rideATAXIA Hometown Twin Cities, MN

Events
News | Oct 8 2024

PTC Therapeutics Announces Positive Results from Long-Term Treatment Studies and Updates on Regulatory Progress for Vatiquinone Friedreich Ataxia Program

Industry News
Blog | Oct 4 2024

Meet the Community 2: A Closer Look — Alijana Shakya 

Community
Blog | Sep 23 2024

Meet the Community 2: A Closer Look – Alex Fielding

Community
News | Sep 20 2024

Congressional Resolution Passes to Designate September 25 as “National Ataxia Awareness Day”

Advocacy
News | Sep 17 2024

Papillon Therapeutics Receives Orphan Drug Designation from the U.S. Food and Drug Administration for PPL-001 for the Treatment of Friedreich’s Ataxia

Industry News
Blog | Sep 16 2024

Meet the Community: Allison Rice

Community
News | Sep 11 2024

Stealth BioTherapeutics Awarded Grant from Friedreich’s Ataxia Research Alliance and FARA Ireland to Develop Investigational Mitochondrial Therapeutic SBT-589 for Friedreich’s Ataxia

FARA News | Industry News | Research